✦ LIBER ✦

Age-related variation in the relationship between menopausal hormone therapy and the risk of dying from breast cancer

✍ Scribed by Kerryn W. Reding; David R. Doody; Anne McTiernan; Li Hsu; Scott Davis; Janet R. Daling; Peggy L. Porter; Kathleen E. Malone

Publisher: Springer US
Year: 2010
Tongue: English
Weight: 206 KB
Volume: 126
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-010-1174-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Polymorphisms in theBRCA1andABCB1genes m

Polymorphisms in theBRCA1andABCB1genes modulate menopausal hormone therapy associated breast cancer risk in postmenopausal women

✍ The MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone The 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 193 KB

Polymorphisms in genes of the steroid re

Polymorphisms in genes of the steroid receptor superfamily modify postmenopausal breast cancer risk associated with menopausal hormone therapy

✍ The MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone The 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 183 KB 👁 1 views

## Abstract Menopausal hormone therapy (HT) is associated with increased breast cancer risk among postmenopausal women. Nuclear receptors are involved in steroid hormone‐ and xenobiotic‐mediated signal transduction playing a crucial role in regulating gene expression. Therefore, variations within t

Menopausal hormone therapy and breast ca

Menopausal hormone therapy and breast cancer risk: Impact of different treatments. The European Prospective Investigation into Cancer and Nutrition

✍ Kjersti Bakken; Agnès Fournier; Eiliv Lund; Marit Waaseth; Vanessa Dumeaux; Fran 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 179 KB 👁 2 views

## Abstract Menopausal hormone therapy (MHT) is characterized by use of different constituents, regimens and routes of administration. We investigated the association between the use of different types of MHT and breast cancer risk in the EPIC cohort study. The analysis is based on data from 133,74

Menopausal hormone therapy and risk of c

Menopausal hormone therapy and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition

✍ Konstantinos K. Tsilidis; Naomi E. Allen; Timothy J. Key; Miguel A. SanJoaquin; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 303 KB 👁 2 views

## Abstract Menopausal hormone therapy (HT) may influence colorectal cancer risk. A total of 136,275 postmenopausal women from the European Prospective Investigation into Cancer and Nutrition were followed for an average of 9 years, during which time 1,186 colorectal cancers were diagnosed. Hazard

Menopausal hormone therapy and risk of o

Menopausal hormone therapy and risk of ovarian cancer in the European prospective investigation into cancer and nutrition

✍ Konstantinos K. Tsilidis; Naomi E. Allen; Timothy J. Key; Laure Dossus; Rudolf K 📂 Article 📅 2011 🏛 Springer Netherlands 🌐 English ⚖ 182 KB

Risk of breast cancer in relation to use

Risk of breast cancer in relation to use of combined oral contraceptives near the age of menopause

✍ David B. Thomas; Elizabeth A. Noonan 📂 Article 📅 1991 🏛 Springer Netherlands 🌐 English ⚖ 467 KB

Data from a multinational, hospital-based, case-control study were analyzed to determine whether use of combined oral contraceptives (OC) around the time of menopause preferentially increases risk of breast cancer. Results show that the relative risk (RR) of breast cancer was increased in women of a